We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.80 | -4.59% | 58.20 | 57.00 | 60.20 | 61.60 | 58.20 | 61.00 | 2,382 | 02:01:28 |
Hot Features
Premium
RNS Number:4651U
CeNeS Pharmaceuticals PLC
21 January 2004
CENES PHARMACEUTICALS PLC ("the Company")
HOLDING IN COMPANY
The Company was informed on 20 January 2004 that Prudential plc has an interest
in 12,500,000 ordinary shares of 1p each in the capital of the Company
representing 4.99 per cent. of the issued share capital of the Company.
Further information
Neil Clark, CeNeS Pharmaceuticals plc 01223 226 466
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUARRRSORAUAR
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
